» Articles » PMID: 24806449

The Down Syndrome-related Protein Kinase DYRK1A Phosphorylates P27(Kip1) and Cyclin D1 and Induces Cell Cycle Exit and Neuronal Differentiation

Overview
Journal Cell Cycle
Specialty Cell Biology
Date 2014 May 9
PMID 24806449
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

A fundamental question in neurobiology is how the balance between proliferation and differentiation of neuronal precursors is maintained to ensure that the proper number of brain neurons is generated. Substantial evidence implicates DYRK1A (dual specificity tyrosine-phosphorylation-regulated kinase 1A) as a candidate gene responsible for altered neuronal development and brain abnormalities in Down syndrome. Recent findings support the hypothesis that DYRK1A is involved in cell cycle control. Nonetheless, how DYRK1A contributes to neuronal cell cycle regulation and thereby affects neurogenesis remains poorly understood. In the present study we have investigated the mechanisms by which DYRK1A affects cell cycle regulation and neuronal differentiation in a human cell model, mouse neurons, and mouse brain. Dependent on its kinase activity and correlated with the dosage of overexpression, DYRK1A blocked proliferation of SH-SY5Y neuroblastoma cells within 24 h and arrested the cells in G₁ phase. Sustained overexpression of DYRK1A induced G₀ cell cycle exit and neuronal differentiation. Furthermore, we provide evidence that DYRK1A modulated protein stability of cell cycle-regulatory proteins. DYRK1A reduced cellular Cyclin D1 levels by phosphorylation on Thr286, which is known to induce proteasomal degradation. In addition, DYRK1A phosphorylated p27(Kip1) on Ser10, resulting in protein stabilization. Inhibition of DYRK1A kinase activity reduced p27(Kip1) Ser10 phosphorylation in cultured hippocampal neurons and in embryonic mouse brain. In aggregate, these results suggest a novel mechanism by which overexpression of DYRK1A may promote premature neuronal differentiation and contribute to altered brain development in Down syndrome.

Citing Articles

Unlocking the Therapeutic Potential of the Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A Inhibitors in Alzheimer's Diseases.

Karati D, Meur S, Saha A, Saha T, Sen A Mol Neurobiol. 2025; .

PMID: 40044956 DOI: 10.1007/s12035-025-04806-8.


Promotion of beta cell proliferation through DYRK kinase inhibition using the marine natural product breitfussin C.

Ullsten S, Hansen K, Petit G, Hansen E, Hammer Andersen J Sci Rep. 2025; 15(1):1247.

PMID: 39774736 PMC: 11706957. DOI: 10.1038/s41598-025-85178-w.


Discovering a novel dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) inhibitor and its impact on tau phosphorylation and amyloid-β formation.

Tu H, Chao M, Lee C, Peng C, Wu Y, Lin T J Enzyme Inhib Med Chem. 2024; 39(1):2418470.

PMID: 39494990 PMC: 11536634. DOI: 10.1080/14756366.2024.2418470.


DYRK1A interacts with the tuberous sclerosis complex and promotes mTORC1 activity.

Wang P, Sarkar S, Zhang M, Xiao T, Kong F, Zhang Z Elife. 2024; 12.

PMID: 39436397 PMC: 11495841. DOI: 10.7554/eLife.88318.


Differential regulation of expression of the protein kinases DYRK1A and DYRK1B in cancer cells.

Vorwerk V, Wilms G, Babendreyer A, Becker W Sci Rep. 2024; 14(1):23926.

PMID: 39397076 PMC: 11471791. DOI: 10.1038/s41598-024-74190-1.


References
1.
Lee M, Tuttle J, REBHUN L, Cleveland D, Frankfurter A . The expression and posttranslational modification of a neuron-specific beta-tubulin isotype during chick embryogenesis. Cell Motil Cytoskeleton. 1990; 17(2):118-32. DOI: 10.1002/cm.970170207. View

2.
Sadasivam S, DeCaprio J . The DREAM complex: master coordinator of cell cycle-dependent gene expression. Nat Rev Cancer. 2013; 13(8):585-95. PMC: 3986830. DOI: 10.1038/nrc3556. View

3.
Salomoni P, Calegari F . Cell cycle control of mammalian neural stem cells: putting a speed limit on G1. Trends Cell Biol. 2010; 20(5):233-43. DOI: 10.1016/j.tcb.2010.01.006. View

4.
Tahtouh T, Elkins J, Filippakopoulos P, Soundararajan M, Burgy G, Durieu E . Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B. J Med Chem. 2012; 55(21):9312-30. DOI: 10.1021/jm301034u. View

5.
Hammerle B, Elizalde C, Tejedor F . The spatio-temporal and subcellular expression of the candidate Down syndrome gene Mnb/Dyrk1A in the developing mouse brain suggests distinct sequential roles in neuronal development. Eur J Neurosci. 2008; 27(5):1061-74. DOI: 10.1111/j.1460-9568.2008.06092.x. View